Finance

Lists
Why is FAE up 2,71%?
Dive Deeper
FAE:BME
FAES Farma SA
4,93 €
+2,71%
(+0,13) 1D
14 հոկ, 17:36:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FAE...
Open
4,82 €
High
4,93 €
Low
4,82 €
Mkt. cap
1,47 մլրդ
Avg. vol.
197,28 հզր
Volume
137,45 հզր
Dividend
2,60%
Quarterly dividend
0,03 €
Ex-dividend date
02 հլս, 2026 թ.
P/E ratio
18,34
52-wk high
5,44 €
52-wk low
4,32 €
EPS
0,27 €
Shares outstanding
316,22 մլն
No. of employees
3 հզր
Open
4,82 €
High
4,93 €
Low
4,82 €
Mkt. cap
1,47 մլրդ
Avg. vol.
197,28 հզր
Volume
137,45 հզր
Dividend
2,60%
Quarterly dividend
0,03 €
Ex-dividend date
02 հլս, 2026 թ.
P/E ratio
18,34
52-wk high
5,44 €
52-wk low
4,32 €
EPS
0,27 €
Shares outstanding
316,22 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Profile
Faes Farma, originally Fábrica Española de Productos Químicos y Farmacéuticos, is a Spanish pharmaceutical company based in the Lamiaco district of Lejona in Biscay. Founded on 29 July 1933 by the Serra family with an initial capital of two million pesetas, it pioneered the development of various therapeutic compounds and has been listed on the Madrid Stock Exchange since the 1940s. Faes Farma’s headquarters, production facilities, and R&D center are located in Lejona, with additional offices in Madrid and Barcelona. The group also operates subsidiaries in Portugal, Italy, Mexico, Guatemala, Colombia, Chile, Peru, Bolivia, Ecuador and Nigeria, and maintains an animal nutrition and health division under the name FARM Faes. Wikipedia
About FAES Farma SA
CEO-
Employees2,61 հզր
Founded29 հլս, 1933 թ.
Headquarters-
Sector-
Last report
30 հլս, 2026 թ.
Fiscal period
Q2 2026
0,09 € / -
0,00%miss
Revenue / Est. (EUR)
401,85 մլն / 189,65 մլն
+111,89%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
146,61 մլն
172,99 մլն
200,07 մլն
191,39 մլն
Cost of goods sold
52,40 մլն
73,44 մլն
61,59 մլն
60,25 մլն
Cost of revenue
52,40 մլն
73,44 մլն
61,59 մլն
60,25 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,36 մլն
80,84 մլն
45,67 մլն
44,06 մլն
Operating expense
68,06 մլն
98,44 մլն
100,13 մլն
98,54 մլն
Total operating expenses
120,47 մլն
171,88 մլն
161,72 մլն
158,78 մլն
Operating income
26,14 մլն
1,11 մլն
38,35 մլն
32,61 մլն
Other non operating income
401,00 հզր
1,02 մլն
-
-
EBT including unusual items
25,18 մլն
-1,39 մլն
36,36 մլն
30,47 մլն
EBT excluding unusual items
25,18 մլն
-1,65 մլն
36,36 մլն
30,47 մլն
Income tax expense
3,75 մլն
-7,43 մլն
5,49 մլն
4,32 մլն
Effective tax rate
14,91%
534,46%
15,10%
14,19%
Other operating expenses
33,65 մլն
7,21 մլն
44,62 մլն
44,44 մլն
Net income
21,23 մլն
6,07 մլն
30,79 մլն
26,10 մլն
Net profit margin
14,48%
3,51%
15,39%
13,64%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
1,41 մլն
Interest expense
-1,99 մլն
-3,51 մլն
-1,99 մլն
-3,58 մլն
Net interest expenses
-1,99 մլն
-3,51 մլն
-1,99 մլն
-2,18 մլն
Depreciation and amortization charges
7,05 մլն
10,39 մլն
9,83 մլն
10,04 մլն
EBITDA
30,15 մլն
6,94 մլն
44,19 մլն
40,50 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps